Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Neoplasms × Colony-Stimulating Factors × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Advanced Malignant Solid Tumor 2 Resectable Pancreatic Cancer 1 Resectable Esophageal Cancer 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neuroblastoma 1 Neoplasms 1 Melanoma 1 Locally Advanced Pancreatic Adenocarcinoma 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Ductal, Breast 1 Brain Neoplasms 1 Astrocytoma 1 Adenoma, Islet Cell 1

Interventions

pembrolizumab 66 Paclitaxel 56 Gemcitabine 50 Carboplatin 50 Cisplatin 39 Docetaxel 36 Bevacizumab 33 Nivolumab 28 Irinotecan 25 Pemetrexed 24 Cyclophosphamide 24 Fluorouracil 23 Capecitabine 22 Erlotinib Hydrochloride 20 venetoclax 19 Cetuximab 19 trametinib 17 Leucovorin 16 Topotecan 15 Afatinib 15 fludarabine 14 Radiotherapy 14 130-nm albumin-bound paclitaxel 14 regorafenib 13 budigalimab 13 Sorafenib 13 Oxaliplatin 13 atezolizumab 12 Doxorubicin 12 Dexamethasone 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05421897 2026-01-29

RAPID

Children's Hospital Los Angeles

Phase 1 Active not recruiting

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡